Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.

Alteri C, Scutari R, Stingone C, Maffongelli G, Brugneti M, Falasca F, Martini S, Bertoli A, Turriziani O, Sarmati L, Coppola N, Andreoni M, Santoro MM, Perno CF, Ceccherini-Silberstein F, Svicher V.

J Clin Virol. 2019 Jun 14;117:61-67. doi: 10.1016/j.jcv.2019.06.004. [Epub ahead of print]

PMID:
31229934
2.

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy.

Fabeni L, Alteri C, Berno G, Scutari R, Orchi N, De Carli G, Bertoli A, Carioti L, Gori C, Forbici F, Salpini R, Vergori A, Gagliardini R, Cicalini S, Mondi A, Pinnetti C, Mazzuti L, Turriziani O, Colafigli M, Borghi V, Montella F, Pennica A, Lichtner M, Girardi E, Andreoni M, Mussini C, Antinori A, Ceccherini-Silberstein F, Perno CF, Santoro MM; SENDIH Study group.

Sex Transm Infect. 2019 May 10. pii: sextrans-2019-054017. doi: 10.1136/sextrans-2019-054017. [Epub ahead of print]

PMID:
31076456
3.

Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients.

Santinelli L, Statzu M, Pierangeli A, Frasca F, Bressan A, Pinacchio C, Nonne C, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C.

Cytokine. 2019 Aug;120:273-281. doi: 10.1016/j.cyto.2019.01.012. Epub 2019 Mar 23.

PMID:
30910260
4.

Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients.

Statzu M, Santinelli L, Viscido A, Pinacchio C, Ceccarelli G, Rotondo C, Corano Scheri G, Mezzaroma I, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C.

Med Microbiol Immunol. 2018 Dec 18. doi: 10.1007/s00430-018-0574-x. [Epub ahead of print]

PMID:
30564919
5.

Copy-Years Viremia and Risk of Virological Failure in Long-Term-Treated HIV Patients.

Falasca F, De Vito C, Mazzuti L, di Carlo D, Celani L, Fimiani C, dʼEttorre G, Mezzaroma I, Antonelli G, Turriziani O.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):423-428. doi: 10.1097/QAI.0000000000001931.

PMID:
30531307
6.

Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient.

Caccuri F, Muraro E, Gloghini A, Turriziani O, Riminucci M, Giagulli C, Mastorci K, Fae' DA, Fiorentini S, Caruso A, Carbone A, Dolcetti R.

Hematol Oncol. 2019 Apr;37(2):176-184. doi: 10.1002/hon.2562. Epub 2018 Nov 6.

PMID:
30261551
7.

Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming.

Capuano C, Battella S, Pighi C, Franchitti L, Turriziani O, Morrone S, Santoni A, Galandrini R, Palmieri G.

Front Immunol. 2018 May 11;9:1031. doi: 10.3389/fimmu.2018.01031. eCollection 2018.

8.

Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.

Di Pietro M, Filardo S, Falasca F, Turriziani O, Sessa R.

Int J Mol Sci. 2017 Nov 18;18(11). pii: E2459. doi: 10.3390/ijms18112459. Review.

9.

Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns.

Falasca F, Di Carlo D, De Vito C, Bon I, d'Ettorre G, Fantauzzi A, Mezzaroma I, Fimiani C, Re MC, Vullo V, Antonelli G, Turriziani O.

BMC Infect Dis. 2017 Aug 22;17(1):581. doi: 10.1186/s12879-017-2676-2.

10.

Dolutegravir-based regimen maintains virological success in a patient with archived mutations to integrase inhibitors.

Mazzuti L, Mezzaroma I, Falasca F, Turriziani O.

AIDS. 2017 Aug 24;31(13):1900-1901. doi: 10.1097/QAD.0000000000001581. No abstract available.

PMID:
28746089
11.

Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.

Andreis S, Basso M, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Panese S, Rossi MC, Francavilla E, Boldrin C, Alvarez M, Dal Bello F, Mengoli C, Turriziani O, Sarmati L, Antonelli G, Andreoni M, Palù G, Parisi SG.

J Glob Antimicrob Resist. 2017 Sep;10:106-112. doi: 10.1016/j.jgar.2017.05.011. Epub 2017 Jul 18.

PMID:
28732792
12.

Consolidation of molecular testing in clinical virology.

Scagnolari C, Turriziani O, Monteleone K, Pierangeli A, Antonelli G.

Expert Rev Anti Infect Ther. 2017 Apr;15(4):387-400. doi: 10.1080/14787210.2017.1271711. Epub 2016 Dec 24. Review.

PMID:
28002969
13.

Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1.

Montagna C, Mazzuti L, Falasca F, Maida P, Bucci M, D'Ettorre G, Mezzaroma I, Fantauzzi A, Alvaro N, Vullo V, Antonelli G, Turriziani O.

J Glob Antimicrob Resist. 2015 Dec;3(4):267-272. doi: 10.1016/j.jgar.2015.07.006. Epub 2015 Aug 22.

PMID:
27842871
14.

Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients.

Sessa R, Di Pietro M, Filardo S, Bressan A, Mazzuti L, Serafino S, Fantauzzi A, Turriziani O.

New Microbiol. 2017 Jan;40(1):33-37. Epub 2016 Nov 7.

15.

Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment.

Massimi I, Lotti LV, Temperilli F, Mancone M, Sardella G, Calcagno S, Turriziani O, Frati L, Pulcinelli FM.

Thromb Haemost. 2016 Nov 30;116(6):1100-1110. Epub 2016 Sep 29.

PMID:
27683757
16.

IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection.

Monteleone K, Scheri GC, Statzu M, Selvaggi C, Falasca F, Giustini N, Mezzaroma I, Turriziani O, d'Ettorre G, Antonelli G, Scagnolari C.

Arch Virol. 2016 Nov;161(11):3263-8. doi: 10.1007/s00705-016-3016-3. Epub 2016 Aug 24.

PMID:
27558125
17.

Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia.

Mazzuti L, Lozzi MA, Riva E, Maida P, Falasca F, Antonelli G, Turriziani O.

New Microbiol. 2016 Jul;39(3):224-227. Epub 2016 Jun 10.

18.

First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing.

Meini G, Dello Russo C, Allice T, Barresi R, D'Arrigo R, Falasca F, Lipsi MR, Paolucci S, Zanussi S, Antonetti R, Baldanti F, Basaglia G, Bruzzone B, Polilli E, Ghisetti V, Pucillo LP, Turriziani O, Pirazzoli A, Navarra P, Zazzi M.

J Clin Virol. 2016 May;78:1-3. doi: 10.1016/j.jcv.2016.02.020. Epub 2016 Feb 23.

PMID:
26946153
19.

Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patients.

Vicenti I, Falasca F, Sticchi L, Bruzzone B, Turriziani O, Zazzi M.

J Clin Virol. 2016 Mar;76:20-3. doi: 10.1016/j.jcv.2016.01.006. Epub 2016 Jan 12.

PMID:
26802683
20.

Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.

d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.

J Med Virol. 2016 Aug;88(8):1347-56. doi: 10.1002/jmv.24475. Epub 2016 Jan 20.

PMID:
26765625
21.

Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients.

Falasca F, Dello Russo C, Mora B, Pirazzoli A, Fantauzzi A, Navarra P, Pizzuti A, De Vito C, Antonelli G, Turriziani O.

AIDS Res Hum Retroviruses. 2016 Jul;32(7):654-7. doi: 10.1089/AID.2015.0303. Epub 2016 Feb 10.

22.

ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.

Scagnolari C, Monteleone K, Selvaggi C, Pierangeli A, D'Ettorre G, Mezzaroma I, Turriziani O, Gentile M, Vullo V, Antonelli G.

Immunobiology. 2016 Feb;221(2):282-90. doi: 10.1016/j.imbio.2015.10.007. Epub 2015 Oct 30.

PMID:
26563749
23.

An epidemiological investigation to reconstruct a probable human immunodeficiency virus-1 transmission network: a case report.

Serafino S, Cella E, Montagna C, Cavallari EN, Vittozzi P, Lo Presti A, Giovanetti M, Mazzuti L, Turriziani O, Ceccarelli G, d'Ettorre G, Vullo V, Ciccozzi M.

J Med Case Rep. 2015 Nov 3;9:253. doi: 10.1186/s13256-015-0717-2.

24.

Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimization.

Fantauzzi A, Floridia M, Falasca F, Spanedda P, Turriziani O, Vullo V, Mezzaroma I.

New Microbiol. 2015 Oct;38(4):531-40. Epub 2015 Oct 20.

25.

Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial.

d'Ettorre G, Ceccarelli G, Giustini N, Serafino S, Calantone N, De Girolamo G, Bianchi L, Bellelli V, Ascoli-Bartoli T, Marcellini S, Turriziani O, Brenchley JM, Vullo V.

PLoS One. 2015 Sep 16;10(9):e0137200. doi: 10.1371/journal.pone.0137200. eCollection 2015.

26.

MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients.

Monteleone K, Selvaggi C, Cacciotti G, Falasca F, Mezzaroma I, D'Ettorre G, Turriziani O, Vullo V, Antonelli G, Scagnolari C.

BMC Infect Dis. 2015 Feb 12;15:51. doi: 10.1186/s12879-015-0768-4.

27.

Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen.

Falasca F, Mazzuti L, DʼEttorre G, Paoletti F, Tripolino O, Serafino S, Antonelli G, Turriziani O.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):e18-20. doi: 10.1097/QAI.0000000000000414. No abstract available.

PMID:
25590274
28.

Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients.

Falasca F, Maida P, Gaeta A, Verzaro S, Mezzaroma I, Fantauzzi A, Donato G, Bonci E, Castilletti C, Antonelli G, Turriziani O.

Infection. 2014 Dec;42(6):1033-7. doi: 10.1007/s15010-014-0690-5. Epub 2014 Oct 18.

PMID:
25326253
29.

V3 net charge: additional tool in HIV-1 tropism prediction.

Montagna C, De Crignis E, Bon I, Re MC, Mezzaroma I, Turriziani O, Graziosi C, Antonelli G.

AIDS Res Hum Retroviruses. 2014 Dec;30(12):1203-12. doi: 10.1089/aid.2014.0006.

PMID:
25322170
30.

Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment.

Riva E, Scagnolari C, Turriziani O, Antonelli G.

Clin Microbiol Infect. 2014 Dec;20(12):1237-45. doi: 10.1111/1469-0691.12797. Epub 2014 Dec 12. Review.

31.

Genetic analyses of HIV-1 pol sequences from Zimbabwean patients.

Falasca F, Temperoni C, Mazzuti L, Lo Presti A, Ciccozzi M, Di Filippo E, Iaiani G, Taliani G, Turriziani O.

New Microbiol. 2014 Jul;37(3):377-81. Epub 2014 Jul 1.

32.

HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.

Bon I, Turriziani O, Musumeci G, Clò A, Montagna C, Morini S, Calza L, Gibellini D, Antonelli G, Re MC.

J Med Virol. 2015 Feb;87(2):315-22. doi: 10.1002/jmv.24036. Epub 2014 Aug 20.

PMID:
25138591
33.

Infectious burden and atherosclerosis: A clinical issue.

Sessa R, Pietro MD, Filardo S, Turriziani O.

World J Clin Cases. 2014 Jul 16;2(7):240-9. doi: 10.12998/wjcc.v2.i7.240. Review.

34.

Early collection of saliva specimens from Bell's palsy patients: quantitative analysis of HHV-6, HSV-1, and VZV.

Turriziani O, Falasca F, Maida P, Gaeta A, De Vito C, Mancini P, De Seta D, Covelli E, Attanasio G, Antonelli G.

J Med Virol. 2014 Oct;86(10):1752-8. doi: 10.1002/jmv.23917. Epub 2014 Mar 12.

PMID:
24619963
35.

Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.

Monteleone K, Di Maio P, Cacciotti G, Falasca F, Fraulo M, Falciano M, Mezzaroma I, D'Ettorre G, Turriziani O, Scagnolari C.

Med Microbiol Immunol. 2014 Jun;203(3):207-16. doi: 10.1007/s00430-014-0329-2. Epub 2014 Feb 20.

PMID:
24553842
36.

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group.

Svicher V, Alteri C, Montano M, Nori A, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Barresi R, Calderisi S, Callegaro AP, Capobianchi MR, Gargiulo F, Castelli F, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Santo F, Fadda G, Galli M, Gennari W, Ghisetti V, Costantini A, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Nozza S, Paolucci S, Palù G, Parisi S, Parruti G, Pignataro AR, Quirino T, Re MC, Rizzardini G, Sanguinetti M, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Viscoli C, Vullo V, Zazzi M, Lazzarin A, Perno CF.

Infection. 2014 Feb;42(1):61-71. doi: 10.1007/s15010-013-0510-3. Epub 2013 Oct 22.

37.

Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up.

Falasca F, Montagna C, Maida P, Bucci M, Fantauzzi A, Mezzaroma I, Antonelli G, Turriziani O.

Clin Microbiol Infect. 2013 Jul;19(7):E318-21. doi: 10.1111/1469-0691.12175. Epub 2013 Feb 26.

38.

Potential benefit of dolutegravir once daily: efficacy and safety.

Fantauzzi A, Turriziani O, Mezzaroma I.

HIV AIDS (Auckl). 2013;5:29-40. doi: 10.2147/HIV.S27765. Epub 2013 Feb 7.

39.

Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis.

Cagliuso M, Conti V, Trasarti S, Lombardi L, Riminucci M, Perez M, Turriziani O, Falasca F, Nanni M, Tafuri A, Mezzaroma I.

Infection. 2013 Feb;41(1):255-8. doi: 10.1007/s15010-012-0344-4. Epub 2012 Sep 25.

PMID:
23007326
40.

Antiviral therapy: old and current issues.

Antonelli G, Turriziani O.

Int J Antimicrob Agents. 2012 Aug;40(2):95-102. doi: 10.1016/j.ijantimicag.2012.04.005. Epub 2012 Jun 21. Review.

PMID:
22727532
41.

Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.

Svicher V, Alteri C, Montano M, D'Arrigo R, Andreoni M, Angarano G, Antinori A, Antonelli G, Allice T, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bon I, Bruzzone B, Callegaro AP, Capobianchi MR, Carosi G, Cauda R, Ceccherini-Silberstein F, Clementi M, Chirianni A, Colafigli M, D'Arminio Monforte A, De Luca A, Di Biagio A, Di Nicuolo G, Di Perri G, Di Pietro M, Di Santo F, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori C, Gori A, Gulminetti R, Leoncini F, Maffongelli G, Maggiolo F, Manca G, Gargiulo F, Martinelli C, Maserati R, Mazzotta F, Meini G, Micheli V, Monno L, Mussini C, Narciso P, Nozza S, Paolucci S, Pal G, Parisi S, Parruti G, Pignataro AR, Pollicita M, Quirino T, Re MC, Rizzardini G, Santangelo R, Scaggiante R, Sterrantino G, Turriziani O, Vatteroni ML, Vecchi L, Viscoli C, Vullo V, Zazzi M, Lazzarini A, Perno CF; DIVA group.

New Microbiol. 2012 Jan;35(1):17-25. Epub 2012 Jan 10.

42.

Short communication: analysis of the integrase gene from HIV type 1-positive patients living in a rural area of West Cameroon.

Turriziani O, Montagna C, Falasca F, Bucci M, Russo G, Lichtner M, Sobze MS, Vullo V, Pistello M, Antonelli G.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1729-33. doi: 10.1089/AID.2011.0266. Epub 2012 Mar 2.

PMID:
22214532
43.

Interferon-induced gene expression in cervical mucosa during human papillomavirus infection.

Pierangeli A, Degener AM, Ferreri ML, Riva E, Rizzo B, Turriziani O, Luciani S, Scagnolari C, Antonelli G.

Int J Immunopathol Pharmacol. 2011 Jan-Mar;24(1):217-23.

PMID:
21496405
44.

Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes.

Scagnolari C, Trombetti S, Soldà A, Selvaggi C, Monteleone K, Spano L, Pierangeli A, Clementi M, Turriziani O, Antonelli G.

J Interferon Cytokine Res. 2011 Jun;31(6):475-9. doi: 10.1089/jir.2010.0125. Epub 2011 Jan 15.

PMID:
21235413
45.

Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients: follow-up at 48 weeks after the beginning of therapy.

Falasca F, Maida P, Montagna C, Antonelli L, d'Ettorre G, Monteleone K, Antonelli G, Turriziani O.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e54-6. doi: 10.1097/QAI.0b013e3181fe4c89. No abstract available.

PMID:
21233632
46.

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.

Svicher V, D'Arrigo R, Alteri C, Andreoni M, Angarano G, Antinori A, Antonelli G, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bonn I, Bruzzone B, Callegaro AP, Cammarota R, Canducci F, Ceccherini-Silberstein F, Clementi M, Monforte AD, De Luca A, Di Biagio A, Di Gianbenedetto S, Di Perri G, Di Pietro M, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori A, Leoncini F, Maggiolo F, Maserati R, Mazzotta F, Micheli V, Meini G, Monno L, Mussini C, Nozza S, Paolucci S, Parisi S, Pecorari M, Pizzi D, Quirino T, Re MC, Rizzardini G, Santangelo R, Soria A, Stazi F, Sterrantino G, Turriziani O, Viscoli C, Vullo V, Lazzarin A, Perno CF; OSCAR Study Group.

New Microbiol. 2010 Jul;33(3):195-206.

47.

Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection.

Turriziani O, Andreoni M, Antonelli G.

Clin Microbiol Infect. 2010 Oct;16(10):1518-24. doi: 10.1111/j.1469-0691.2010.03329.x. Review.

48.

Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients.

Turriziani O, Boni A, Falasca F, Graziano F, Bucci M, D'Ettorre G, Fantauzzi A, Paoletti F, Massetti AP, Mezzaroma I, Antonelli G.

AIDS Res Hum Retroviruses. 2010 Jun;26(6):625-34. doi: 10.1089/aid.2009.0183.

PMID:
20507206
49.

Thymidine kinase and deoxycytidine kinase in HIV-infected children.

Falasca F, Maida P, Boni A, Bernardi S, Cursi L, Rizzo B, Antonelli G, Gattinara GC, Turriziani O.

New Microbiol. 2009 Oct;32(4):411-3.

50.

Non-steroidal anti-inflammatory drugs increase the antiretroviral activity of nucleoside reverse transcriptase inhibitors in HIV type-1-infected T-lymphocytes: role of multidrug resistance protein 4.

Clemente MI, Alvarez S, Serramía MJ, Turriziani O, Genebat M, Leal M, Fresno M, Muñoz-Fernández MA.

Antivir Ther. 2009;14(8):1101-11. doi: 10.3851/IMP1468.

PMID:
20032540

Supplemental Content

Loading ...
Support Center